News from Amgen
Stay current with all the latest and breaking news about Amgen, compare headlines and perspectives between news sources on stories happening today. In total, 49 stories have been published about Amgen which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Amgen News
Latest News Stories
Amgen · ChicagoAmgen headquarters in Thousand Oaks, California.Adobe Stock When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July. His tumors shrank, then stabilized.But while the drug has helped keep him alive, its side effects have gradually narrowed the confines of his life, says Cro…See the Story
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
100% Left coverage: 1 sources
Amgen · Thousand OaksWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July. His tumors shrank, then stabilized.See the Story
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
100% Center coverage: 1 sources
Immigration · United StatesThe FDA told Amgen to test whether a quarter-dose of a lung cancer drug worked as well as Amgen’s recommended amount. It did, with fewer side effects. But cutting the dose means less revenue.See the Story
Analysis | The FDA targets pharma’s grip on costly, toxic cancer drug dosages
100% Left coverage: 1 sources
AmgenAs the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on the trend.See the Story
Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update - ARK Genomic Revolution ETF (BATS:ARKG), Amgen (NASDAQ:AMGN)
100% Center coverage: 1 sources
JobsA weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expectations on potential interest rate cuts later this year. In April, nonfarm payrolls expanded by 175,000 jobs, marking a significant slowdown from March’s robust pace of 315,000 and notably falling short of the anticipated 238,000. Unexpectedly, the unemployment rate edged higher, while average hourly earnings softened m…See the Story
Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday? - Amgen (NASDAQ:AMGN)
100% Center coverage: 1 sources
Stock MarketsA new study looked at whether different diabetes drugs may help prevent colon cancer, and found GLP-1 medications like semaglutide may significantly reduce the risk.CR/Getty ImagesAmgen stock soared as much as 16% on Friday after it reported first-quarter earnings.The company talked up its experimental GLP-1 weight-loss drug, MariTide.The new weight loss drug could be injected monthly instead of weekly.A new experimental weight-loss drug helped …See the Story
Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of weekly
100% Left coverage: 1 sources